GSTM1 and colorectal carcinoma: While certain time points, such as preoperative and intraoperative, did not show statistically significant differences in the need for RBCT, the overall trends in Hb improvement, decreased overall need for RBCT, and reduced complications suggest that IVI supplementation could be a valuable adjunct in the management of CRC patients undergoing surgery.